Whatceff 200 DT Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Lactobacillus 2.5 Billion Spores, designed to treat a variety of bacterial infections while supporting gastrointestinal health. Cefixime, a third-generation cephalosporin antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial cell wall synthesis, making it effective against respiratory tract infections, urinary tract infections, otitis media, and uncomplicated gonorrhea caused by susceptible strains. The inclusion of Lactobacillus, a beneficial probiotic, helps restore and maintain the natural balance of gut flora, which may be disrupted during antibiotic therapy, thereby reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. Whatceff 200 DT is formulated as a dispersible tablet, facilitating ease of administration and improved patient compliance, especially in pediatric and geriatric populations. It is indicated for use under medical supervision, with dosage and duration tailored according to the severity and type of infection. Caution is advised in patients with known hypersensitivity to cephalosporins or penicillins. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions. Whatceff 200 DT should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children.